CLINICAL_TRIALS
trial_result
· 2022-08-10
Clinical Trial Update: A Phase III Study in Subjects With Mild to Moderate Psoriasis. [Phase 3]
Summary
A Phase III clinical trial update for subjects with mild to moderate psoriasis is reported, with phase and status currently UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lipidor AB | Conditions: Mild to Moderate Psoriasis | Phase 3 | Status: UNKNOWN